Molecular Dynamics Simulation of Grain Boundary Motion: Methods and Case Studies.
Abstract not provided.
SEARCH · Search NASA
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Abstract not provided.
Abstract not provided.
Purpose: We propose a new type of treatment that employs a modulated and sliding tangential photon field to provide superior coverage of superficial targets when compared to other commonly employed methods while drastically reducing dose to the underlying sensitive structures often present in these cases. Methods: Modulated treatment plans were formulated for a set of three representative cases. The first was a revised treatment of a scalp sarcoma, while the second was a treatment of a right posterior chest wall sarcoma. For these cases, asymmetric jaw placement, angular limitations, and central isocenter placements were used to force the optimization algorithm into finding solutions with beamlines that were not perpendicular to the body surface. The final case targeted the chest wall of a breast cancer patient, in which standard treatments were compared to the use of modulated fields with multiple isocenters along the chest wall. Results: When compared with unrestricted modulated arcs, the tangential arc scalp treatment reduced the max and mean doses delivered to the brain by 33Gy (from 55 to 22Gy) and 6Gy (from 14Gy to 8Gy), respectively. In the right posterior chest wall case, the V10 in the ipsilateral lung was kept below 5% while retaining a Rx dose (45Gy) target coverage of over 97%. For the breast case, the modulated plan achieved reductions in high dose to the ipsilateral lung and heart by a factor of 2–3 when compared to classic laterally opposed tangents and reduced the V5 by 40% when compared to standard modulated arcs. Conclusion: Tangential modulated arc therapy has outperformed the conventional modalities of treatment for superficial lesions used in our clinic. We hope that with the advent of digitally controlled linear accelerators, we can uncover further benefits of this new technique and extend its applicability to a wider section of the patient population.
Purpose: In carbon-ion radiotherapy treatment planning, the planar integrated dose (PID) measured in water is applied to the patient dose calculation with density scaling using the stopping power ratio. Since body tissues are chemically different from water, this dose calculation can be subject to errors, particularly due to differences in inelastic nuclear interactions. In recent studies, the authors proposed and validated a PID correction method for these errors. In the present study, the authors used this correction method to assess the influence of these nuclear interactions in body tissues on tumor dose in various clinical cases. Methods: Using 10–20 cases each of prostate, head and neck (HN), bone and soft tissue (BS), lung, liver, pancreas, and uterine neoplasms, the authors first used treatment plans for carbon-ion radiotherapy without nuclear interaction correction to derive uncorrected dose distributions. The authors then compared these distributions with recalculated distributions using the nuclear interaction correction (corrected dose distributions). Results: Median (25%/75% quartiles) differences between the target mean uncorrected doses and corrected doses were 0.2% (0.1%/0.2%), 0.0% (0.0%/0.0%), −0.3% (−0.4%/−0.2%), −0.1% (−0.2%/−0.1%), −0.1% (−0.2%/0.0%), −0.4% (−0.5%/−0.1%), and −0.3% (−0.4%/0.0%) for the prostate, HN, BS, lung, liver, pancreas, and uterine cases, respectively. The largest difference of −1.6% in target mean and −2.5% at maximum were observed in a uterine case. Conclusions: For most clinical cases, dose calculation errors due to the water nonequivalence of the tissues in nuclear interactions would be marginal compared to intrinsic uncertainties in treatment planning, patient setup, beam delivery, and clinical response. In some extreme cases, however, these errors can be substantial. Accordingly, this correction method should be routinely applied to treatment planning in clinical practice.
Purpose: To incorporate uncertainties in oxygenation of tumor cells into radiation therapy planning via robust optimization. The model is demonstrated using a clinical prostate cancer case. Methods: The tumor oxygenation levels are determined based on pre- and mid-treatment PET scans. To account for oxygenation changes, we use a radio-sensitivity factor for the effective dose necessary to treat hypoxic cells. Due to the unpredictable nature of re-oxygenation of hypoxic cells, the radio-sensitivity factor and its change is modeled to reside in a time-dependent uncertainty set. This uncertainty can adapt to both pre- and mid-treatment scans, resulting in a two-stage robust treatment planning model. We develop a robust counterpart reformulation that transforms the original NP-hard problem into a linear program consisting of finitely many linear constraints, which can be solved efficiently. Results: The robust plan is compared to both the corresponding fractionated plan which ignores hypoxia, and to the commonly practiced dose-escalated plan that uniformly increases dose based on initial oxygen concentrations. For PTV, the robust plan improves D{sub 50}, D{sub 95}, and EUD by 4% on average compared to fractionated, and by 11% compared to the optimal escalated plan. Moreover, the robust plan spared organs at risk similar to the fractionated plan, while the escalated plan led to over 170% increase of Bladder D{sub 30}. Conclusion: The proposed robust adaptive model can improve tumor coverage by increasing dose to hypoxic tumor voxels that is overlooked by common fractionated treatments. In addition, the robust model anticipates the re-oxygenation process, thus reducing the excess dose at later fractions in comparison to uniform dose-escalation methods.
This paper presents the new approach to creation of geometrical module for nuclear reactor neutron transport computer simulation analysis so called the differential cross method. It is elaborated for detecting boards between physical zones. It is proposed to use GMSH open source mesh editor extended by some features: a special option and a special kind of mesh (cubic background mesh).This method is aimed into Monte Carlo Method as well as for deterministic neutron transport methods. Special attention is attended for reactor core composed of a set of material zones with complicate geometrical boundaries. The idea of this approach is described. In general case method works for 3-D space. Algorithm of creation of the geometrical module is given. 2-D neutron transport benchmark-test for RBMK reactor cluster cell is described. It demonstrates the ability of this approach to provide flexible definition of geometrical meshing with preservation of curved surface or any level of heterogeneity. (authors)
Purpose: The reduced concentration of oxygen in cells (hypoxia) results in a lower cell death rate after irradiation that can lead to treatment failure. The effect can be expressed by the oxygen enhancement ratio (OER). So far, only few attempts to include OER in treatment planning for ion beam therapy were made, which are based on the dose averaged LET estimates and do not distinguish among ion species and fractionation schemes. To overcome these limitations, we implemented a new OER model and used it to estimate tumor control in clinical cases. Methods: The model, based on the microdosimetric kinetic model, was benchmarked with in-vitro data from different ions irradiation. It was included in the simulation of treatments of a set of clinical cases (glioblastoma) using p, Li, He, C and O ion beams. Tumor Control Probability (TCP) was estimated as a function of oxygen partial pressure, dose per fraction and primary ion type. Results: The modelized OER was found to be strongly dependent on both LET and ion type, and showed a decreasing OER for increasing dose per fraction with a slope that depends on the LET and ion type, in good agreement with the experimental data. In the clinical cases studied, an increase in TCP by increasing ion charge and dose per fraction (more than 30% variation from p to O for moderate hypoxia) was found. Higher OER decrease rates as function of dose per fraction were found for lighter ions (up to 20% varying from 2 to 8 Gy(RBE)). Conclusions: A novel modeling of the OER that explicitly includes the dependence on ion type and dose per fraction was implemented. The model was exploited to evaluate the impact of hypoxia in ion beam radiotherapy, facilitating the identification of the treatment condition optimality, including fractionation scheme and ion type.
ISO/TS 6336-22 (Calculation of load capacity of spur and helical gears - Part 22: Calculation of micropitting load capacity) is the ISO technical specification containing a proposal for calculations of the risk of micropitting in gear sets. Micropitting is a Hertzian fatigue phenomenon that appears as ultra-fine cracking and pitting on the flanks of gear teeth. Since progressive micropitting can lead to macropitting and flank damage, critical applications such as wind turbines, marine drives, and high-speed gear drives seek to accurately predict whether their designs are susceptible to this damage. ISO/TS 6336-22 assesses micropitting risk through a safety factor which is calculated as the minimum specific film thickness in the contact zone divided by a permissible specific film thickness. In the previous paper, the calculations were performed using the simplified method (Method B) that evaluates points on the path of contact. This was done for three gear sets that experienced micropitting in operation. The minimum specific film thickness for the two field cases was very high, which indicates that the gears were operating in the full elastohydrodynamic lubrication (EHL) regime. A more accurate calculation for these cases (Method A) calculates the specific film thickness across the entire contact zone. This paper applies this Method to the case study from the previous paper. The results are compared to micropitting observed in operation. Results are also compared to the results of the previous paper. Conclusions are made regarding the accuracy of both Methods compared to the field cases and relative to each other.
ISO/TS 6336-22 (Calculation of load capacity of spur and helical gears — Part 22: Calculation of micropitting load capacity) is the ISO technical specification containing a proposal for calculations of the risk of micropitting in gear sets. Micropitting is a Hertzian fatigue phenomenon that appears as ultra-fine cracking and pitting on the flanks of gear teeth. Since progressive micropitting can lead to macropitting and flank damage, critical applications such as wind turbines, marine drives, and high-speed gear drives seek to accurately predict whether their designs are susceptible to this damage. ISO/TS 6336-22 assesses micropitting risk through a safety factor which is calculated as the minimum specific film thickness in the contact zone divided by a permissible specific film thickness. In the previous paper, the calculations were performed using the simplified method (Method B) that evaluates points on the path of contact. This was done for three gear sets that experienced micropitting in operation. The minimum specific film thickness for the two field cases was very high, which indicates that the gears were operating in the full elastohydrodynamic lubrication (EHL) regime. A more accurate calculation for these cases (Method A) calculates the specific film thickness across the entire contact zone. This paper applies this Method to the case study from the previous paper. The results are compared to micropitting observed in operation. Results are also compared to the results of the previous paper. Conclusions are made regarding the accuracy of both Methods compared to the field cases and relative to each other.
ISO/TS 6336-22 (Calculation of load capacity of spur and helical gears - Part 22: Calculation of micropitting load capacity) is the ISO technical specification containing a proposal for calculations of the risk of micropitting in gear sets. Micropitting is a Hertzian fatigue phenomenon that appears as ultra-fine cracking and pitting on the flanks of gear teeth. Since progressive micropitting can lead to macropitting and flank damage, critical applications such as wind turbines, marine drives, and high-speed gear drives seek to accurately predict whether their designs are susceptible to this damage. ISO/TS 6336-22 assesses micropitting risk through a safety factor which is calculated as the minimum specific film thickness in the contact zone divided by a permissible specific film thickness. In the previous paper, the calculations were performed using the simplified method (Method B) that evaluates points on the path of contact. This was done for three gear sets that experienced micropitting in operation. The minimum specific film thickness for the two field cases was very high, which indicates that the gears were operating in the full elastohydrodynamic lubrication (EHL) regime. A more accurate calculation for these cases (Method A) calculates the specific film thickness across the entire contact zone. This paper applies this Method to the case study from the previous paper. The results are compared to micropitting observed in operation. Results are also compared to the results of the previous paper. Conclusions are made regarding the accuracy of both Methods compared to the field cases and relative to each other.
Purpose: To investigate if Dynamic Conformal Arcs (DCA) can be used to achieve similar target coverage and conformality as that of using VMAT for Stereotactic Body Radiation Therapy (SBRT) for Lung cases. Methods: We retrospectively re-planned 11 patients that were treated with SBRT for lung tumors using only a single conformal arc, broken into three or four arc segments and weighted differentially in order to achieve the dosimetric constraints as outlined in RTOG 0915 protocol. These re-plans of using DCA were compared with those of using VMAT in terms of the Planning Tumor Volume (PTV) coverage goals, Maximum Dose 2 cm away (D {sub 2}cm), High Dose Spillage, Intermediate Dose Spillage, Lung volume getting 5 Gy (V{sub 5}), and number of monitor units (MU). Results: Of the 11 cases, only three DCA plans failed the D{sub 2}cm parameter, and one VMAT plan failed. None of the 11 patients failed the High Dose Spillage in either technique. For Intermediate Dose Spillage, one DCA plan failed and none failed for VMAT plans. The average V{sub 5} for DCA was 10.5 percent, with VMAT reporting 11.7 percent. The average number of MU for DCA and VMAT were 2605 and 3451, respectively. Conclusion: DCA is able to achieve very similar treatment planning goals as that of using VMAT in treating SBRT Lung tumors in most cases with simplicity. In addition, the DCA technique produces an acceptable plan with lower V{sub 5} in less MU when dose to OAR concerns are at minimum. However, DCA has shown its limitations when the target is close to multiple OAR.
Purpose: To integrate treatment delivery time into plan optimization in spot scanning intensity modulated proton therapy. Utilizing a dedicated research treatment planning system we present an optimization approach to explore the trade-off between the correlated parameters treatment time and plan quality on an astrocytoma patient case. Methods: The planning system is based on prioritized optimization, a stepwise approach of implementing clinical goals. After each optimization step, dosimetric achievements are turned into hard constraints to maintain the achieved plan quality. Prior achievements can be violated by a so-called slip-factor which allows to study possible trade-offs of conflicting goals. Plan quality is obtained in the first two steps, while the third step optimizes delivery efficiency by working on the spot weight distribution via four alternative Methods: elimination of low weighted spots (1), elimination of spots hardly contributing to PTV dose, followed by reoptimization of the resulting smaller optimization problem (2), reduction of spot weights variance within each energy layer (3), and reduction of the overall spot weight sum (4). Treatment times were calculated assuming either constant or variable beam current depending on the lowest spot weight. Results: Delivery efficiency can be improved remarkably without influencing the plan quality. Absolute time savings depend on the utilized method and facility properties. By varying slip-factor and spot reduction limits, a border of worsening quality is detectable for all methods.Deleting low weighted spots by 10% results in a noticeable decrease in minimum target dose. Further reduction results in more heterogeneous dose distributions and insufficient coverage. Option 2 showed constant plan quality for spot reductions of more than 10%. Conclusion: Including treatment time optimization as a final step into prioritized optimization allows for more efficient treatment plans by redistributing the spot patterns without compromising plan quality, which has to remain the main intent of radiotherapy treatment. The authors report grants from German Research Foundation (DFG) during the conduct of the study.
Purpose: For prostate anatomy, previous investigations have shown that simulated CT (sCT) generated from MR images can be used for accurate dose computation. In this study, we demonstrate the feasibility of MR-only IMRT planning for prostate case. Methods: Regular CT (rCT) and MR images of the same patient were acquired for prostate anatomy. Regions-of-interest (ROIs) i.e. target and risk structures are delineated on the rCT. A simulated CT (sCT) is generated from the MR image using the method described by Schadewaldt N et al. Their work establishes the clinical acceptability of dose calculation results on the sCT when compared to rCT. rCT and sCT are rigidly registered to ensure proper alignment between the two images. rCT and sCT are overlaid on each other and slice-wise visual inspection confirms excellent agreement between the two images. ROIs on the rCT are copied over to sCT. Philips AutoPlanning solution is used for generating treatment plans. The same treatment technique protocol (plan parameters and clinical goals) is used to generate AutoPlan-rCT and AutoPlan-sCT respectively for rCT and and sCT. DVH comparison on ROIs and slice-wise evaluation of dose is performed between AutoPlan-rCT and AutoPlan-sCT. Delivery parameters i.e. beam and corresponding segments from the AutoPlan-sCT are copied over to rCT and dose is computed to get AutoPlan-sCT-on-rCT. Results: Plan evaluation is done based on Dose Volume Histogram (DVH) of ROIs and manual slice-wise inspection of dose distribution. Both AutoPlan-rCT and AutoPlan-sCT provide a clinically acceptable plan. Also, AutoPlan-sCT-on-rCT shows excellent agreement with AutoPlan-sCT. Conclusion: The study demonstrates that it is feasible to do IMRT planning on the simulated CT image obtained from MR image for prostate anatomy. The research is supported by Philips India Ltd.
Purpose: To present a method to evaluate the dose mapping error introduced by the dose mapping process. In addition, apply the method to evaluate the dose mapping error introduced by the 4D dose calculation process implemented in a research version of commercial treatment planning system for a patient case. Methods: The average dose accumulated in a finite volume should be unchanged when the dose delivered to one anatomic instance of that volume is mapped to a different anatomic instance--provided that the tissue deformation between the anatomic instances is mass conserving. The average dose to a finite volume on image S is defined as d{sub S}=e{sub s}/m{sub S}, where e{sub S} is the energy deposited in the mass m{sub S} contained in the volume. Since mass and energy should be conserved, when d{sub S} is mapped to an image R(d{sub S{yields}R}=d{sub R}), the mean dose mapping error is defined as {Delta}d{sub m}=|d{sub R}-d{sub S}|=|e{sub R}/m{sub R}-e{sub S}/m{sub S}|, where the e{sub R} and e{sub S} are integral doses (energy deposited), and m{sub R} and m{sub S} are the masses within the region of interest (ROI) on image R and the corresponding ROI on image S, where R and S are the two anatomic instances from the same patient. Alternatively, application of simple differential propagation yields the differential dose mapping error, {Delta}d{sub d}=|({partial_derivative}d/{partial_derivative}e)*{Delta}e+({partial_derivative}d/{partial_derivative}m)*{Delta}m|=|((e{sub S}-e{sub R})/m{sub R})-((m{sub S}-m{sub R})/m{sub R}{sup 2})*e{sub R}|={alpha}|d{sub R}-d{sub S}| with {alpha}=m{sub S}/m{sub R}. A 4D treatment plan on a ten-phase 4D-CT lung patient is used to demonstrate the dose mapping error evaluations for a patient case, in which the accumulated dose, D{sub R}={Sigma}{sub S=0}{sup 9}d{sub S{yields}R}, and associated error values ({Delta}D{sub m} and {Delta}D{sub d}) are calculated for a uniformly spaced set of ROIs. Results: For the single sample patient dose distribution, the average accumulated differential dose mapping error is 4.3%, the average absolute differential dose mapping error is 10.8%, and the average accumulated mean dose mapping error is 5.0%. Accumulated differential dose mapping errors within the gross tumor volume (GTV) and planning target volume (PTV) are lower, 0.73% and 2.33%, respectively. Conclusions: A method has been presented to evaluate the dose mapping error introduced by the dose mapping process. This method has been applied to evaluate the 4D dose calculation process implemented in a commercial treatment planning system. The method could potentially be developed as a fully-automatic QA method in image guided adaptive radiation therapy (IGART).
Purpose: To compare dose-volume (DVH) and energy minimization-based (EM) optimization for prostate cancer cases. Methods: A dozen of prostate plans were retrospectively studied. For each case two IMRT plans were generated, one with DVH and the other with EM objective cost function. Those different objective functions were used only for the organs at risk (OARs), while target objectives were achieved through DVH cost functions. The plans used the same beam angles, maximum number of segments per plan, minimum segment area and MUs per segment. Both plans were normalized such that 95% of the PTV was covered by the same prescription dose. After prescription was achieved, doses to the OARs were iteratively lowered until the standard deviation of the dose across the PTV was ~3.5%. Plan quality was evaluated by several dose indices (DIs). A DI represents the dose delivered to certain volume of a structure. Tallied DIs were for rectum and bladder 10%, 40%, 60% volumes, and 1% volumes of the femoral heads as surrogate for maximum doses. Statistical significance in the differences among DIs was quantified with two-tailed paired t-tests. Results: On average EM plans performed better than DVH plans. Statistically significant dose reduction in rectum DI10, DI40, and DI60, were 2.6%, 25.7%, and 35.9%, respectively. For bladder DI10, DI40, and DI60 the differences were 1.1%, 20.8%, and 29.7%. Left and right femoral head DI1s were better by 33.8% and 27.8% in EM plans. The quoted dose reduction is with respect to EM absolute doses for the DIs. Conclusion: The performance of EM optimization with respect to DVH optimization is patient and DI dependent. While in some cases specific DIs were better with DVH optimization, on average the energy minimization allows better (ranging from 1% to ~40%) OAR sparing than DVH optimization. NIH-NCI.
Imaging hydraulically active fracture zones (HAFZ) is of paramount importance to subsurface resource extraction, geologic storage, and hazardous waste disposal. We have developed advanced 3D finite-element (FE) electrical imaging algorithms for HAFZ in the presence of a steel-cased well. The algorithms use tetrahedral FE meshes in the simulation domain and coarse rectangular finite-difference meshes in the imaging domain. This heterogeneous dual-mesh approach is well suited to modeling the multiscale earth model due to steel-cased wells. We find that the algorithms accurately and efficiently simulate surface electric field measurements over a 3D HAFZ at depth when one end point of a surface electric source is connected to a wellhead. For brevity, this configuration is called the top-casing electric source method. By replacing a hollow cased well with a solid prism, we improve our computational efficiency without affecting the solution accuracy. The sensitivity of the top-casing source method to HAFZ highly depends on the continuity of a steel-cased well because it makes currents preferentially flow to HAFZ. The sensitivity also depends on conductivity structures around the well because they control current leaking from the steel-cased well. We find that the method can image a localized HAFZ and detect changes in its width and height. Here, the imaging results are improved when a volume of the imaging domain is constrained from geomechanical perspectives. A primary advantage of the method is the fact that the sources and receivers are placed on the surface, thus not interrupting the well operation.
Purpose: To investigate the impact of outliers on knowledge modeling in radiation therapy, and develop a systematic workflow for identifying and analyzing geometric and dosimetric outliers using pelvic cases. Methods: Four groups (G1-G4) of pelvic plans were included: G1 (37 prostate cases), G2 (37 prostate plus lymph node cases), and G3 (37 prostate bed cases) are all clinical IMRT cases. G4 are 10 plans outside G1 re-planned with dynamic-arc to simulate dosimetric outliers. The workflow involves 2 steps: 1. identify geometric outliers, assess impact and clean up; 2. identify dosimetric outliers, assess impact and clean up.1. A baseline model was trained with all G1 cases. G2/G3 cases were then individually added to the baseline model as geometric outliers. The impact on the model was assessed by comparing leverage statistic of inliers (G1) and outliers (G2/G3). Receiver-operating-characteristics (ROC) analysis was performed to determine optimal threshold. 2. A separate baseline model was trained with 32 G1 cases. Each G4 case (dosimetric outliers) was then progressively added to perturb this model. DVH predictions were performed using these perturbed models for remaining 5 G1 cases. Normal tissue complication probability (NTCP) calculated from predicted DVH were used to evaluate dosimetric outliers’ impact. Results: The leverage of inliers and outliers was significantly different. The Area-Under-Curve (AUC) for differentiating G2 from G1 was 0.94 (threshold: 0.22) for bladder; and 0.80 (threshold: 0.10) for rectum. For differentiating G3 from G1, the AUC (threshold) was 0.68 (0.09) for bladder, 0.76 (0.08) for rectum. Significant increase in NTCP started from models with 4 dosimetric outliers for bladder (p<0.05), and with only 1 dosimetric outlier for rectum (p<0.05). Conclusion: We established a systematic workflow for identifying and analyzing geometric and dosimetric outliers, and investigated statistical metrics for detecting. Results validated the necessity for outlier detection and clean-up to enhance model quality in clinical practice. Research Grant: Varian master research grant.
In 2017, as part of the second round of funding from the Washington State Clean Energy Fund, the Washington State Department of Commerce granted up to $\$3$ million in matching funds to develop an estimated $6.5 million project that deployed a 4-MW, 20-acre solar generating array of photovoltaic (PV) panels coupled with a 1 MW/4 MWh (nameplate capacity) lithium-iron-phosphate battery energy storage system (BESS) in Richland, Washington. The combination of PV and BESS will provide a predictable, renewable generating source and will also serve as a training ground for solar and battery technicians throughout the nation. This report documents the techno-economic assessment of the integrated system, including the definition of use cases and applications, collection and preparation of data and input parameters, development of modeling and optimization methods, case studies, and analysis results.